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Prostate cancer is very frequent, but secondary ureteral metastasis are extremely rare. We present a
55 year old man with a 2 month history of right ﬂank pain and lower urinary tract symptoms. Prostatic
speciﬁc antigen of 11.3 ng/mL. Computed tomography showed right hydroureteronephrosis, a developing
urinoma and right iliac adenopathies. He underwent right ureteronephrectomy, iliac lymphadenectomy
and prostate biopsy. Pathology revealed prostatic carcinoma inﬁltrating the ureteral muscularis propria,
without mucosal involvement. There are 46 reported cases of prostate cancer with ureteral metastases.
Ureteral metastasis are a rare cause of renal colic and need of a high index of suspicion.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Figure 1. Computed tomography urogram. Moderated right hydroureteronephrosis is
shown, without left urinary tract involvement.Introduction
Prostate cancer is very frequent in the whole world, with a
global incidence of 25.3 per 100.000 men.1 Most common sites of
metastasis are bones, lung, liver and pleura.2 Despite the high
incidence of this malignancy, secondary ureteral metastases are
extremely rare, with only 46 cases reported to date. We present an
unusual case of symptomatic ureteral metastasis in a previously
healthy 55-year-old man.
Case report
In August 2012, a 55-year-old man without previous morbid
conditions presents with a 2 month history of progressive pain in
the right ﬂank, irradiated to the ipsilateral testicle, associated to
lower urinary tract symptoms, with storage-predominance. No
hematuria was present. He had a PSA of 5.6 ng/mL from a previous
evaluation and a non-contrast computed tomography showing
dilation of the right ureter, with no evident lithiasis. On examina-
tion, he was afebrile, with pain on the right ﬂank at percussion in
the costovertebral angle and at bimanual palpation of the kidney.
There were no palpable masses in the abdomen nor pelvis. On
digital rectal examination, there was an enlarged nodular prostate,
globally indurated.SAP, Prostate speciﬁc acid
ssa).
Inc. This is an open access article uLaboratory showed C-reactive protein of 200 mg/dL and PSA of
11.3 ng/mL. A prostate transrectal needle biopsy was performed.
The computed tomography urogram evidentiated moderated right
hydroureteronephrosis, urine extravasation, apparent developing
urinoma and right iliac adenopathy (Fig. 1). With the intention of
performing right ureteral catheterization, the patient underwent
urethrocystoscopy, which showed an enlarged obstructive prostate,
without invasion to the bladder. Ureteral oriﬁces were both
permeable, but catheterization was impossible due to ureteral
stenosis. In the next 48 hours, the patient developed rapid deteri-
oration of his general clinical status. Because of this and the highnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. Immunohistochemistry of ureteral tissue, with anti-PSA and anti-PSAP.
Cytoplasmic staining of neoplastic cells inﬁltrating the muscularis propria is seen on
the right of the picture.
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onephrectomy plus right iliac lymphadenectomy. Intra-operative
frozen section of lymphadenopathy was informed as undifferenti-
ated adenocarcinoma.
Pathological examination revealed periureteral and perivesical
ﬁbroadipose tissue inﬁltrated by an undifferentiated solid carci-
noma, suggestive of a prostatic adenocarcinoma. This was
conﬁrmed by immunohistochemistry with anti-PSA and anti-PSAP,
where cytoplasmic staining of neoplastic cells inﬁltrating the
muscularis propria was evident. There was no involvement of the
mucosa (Fig. 2). Prostate biopsy showed acinar adenocarcinoma,
Gleason 9 (5 þ 4).
Three months after surgery, bone scintigraphy made evident
bonemetastases inpelvis and right femur. Patientwasmanagedwith
complete androgen blockade. Prostate-speciﬁc antigen decreased to
a nadir of 0.45 ng/mL, before raising to 14.8 ng/mL at 1 year after
surgery. He started on chemotherapy with docetaxel. Focal radio-
therapy was performed for bone pain management. Two years after
the initial diagnosis was made, the patient deceased at his home.
Discussion
Ureteral metastases are very infrequent. The ﬁrst case published
was in the year 1909, by Bond Stow. A review made by Cohen et alshowed that the most frequent primary tumors were originated in
breast, colon, lymphoma and lung, without any prostate cancer
identiﬁed in that review.3 To our knowledge, only 46 cases of ure-
teral metastases secondary to prostate cancer have ever been
published. Of these, about 85% are asymptomatic at diagnosis and
most of them are identiﬁed in patients with known prostate can-
cer.4,5 The mechanism of metastasis is not fully understood.
Lymphatic retrograde dissemination is one of the most accepted
theories and it would be consistent with this case, where ipsilateral
lymph node involvement was present.Conclusion
Ureteral metastases from prostate cancer are extremely infre-
quent in the natural history of this disease. They are usually
asymptomatic and need of a high index of suspicion. Clinicians
should be aware of its existence and suspect it when there is an
unclear cause of ureteral dilation and an elevated PSA. Correct
identiﬁcation of the primary tumor can be crucial for the man-
agement of the disease. This case helps us to keep the awareness of
very severe diseases that can be hidden behind very common
clinical situations, such as the renal colic.Conﬂicts of interest
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